Skip to main content
Glama

Nasa Cmr

by io.github.pipeworx-io

Resolve Entity

resolve_entity
Read-onlyIdempotent

"What's the ticker for…" / "find the CIK for…" / "what's the LEI for…" / "what's the RxCUI for…" / "look up the ID for…" / "what is X's official identifier" / "who owns X" / "is X a subsidiary of Y" — resolve a user-spoken NAME to the canonical/official identifiers other tools require as input. Use FIRST whenever you have a name but need an ID. SUPPORTED TYPES: "company" (cross-source identity spine: 10-digit CIK + ticker + company_name from SEC EDGAR, legal-entity LEI from GLEIF with parent/ultimate-parent/children ownership when the LEI resolves, and security FIGI from OpenFIGI — by exact ticker map when a ticker is implied, and otherwise by name search, so NON-EQUITY instruments that never have a ticker (municipal and corporate bonds, notes, authority debt) DO resolve here; when a name matches more than one instrument it asserts nothing and returns figi_candidates to pick from, which is the correct answer to an issuer name that does not identify a single bond; every identifier is labelled with the source that established it, and an identifier that could NOT be resolved is stated explicitly under unresolved rather than omitted — accepts ticker, CIK, ISIN, or company name as input; an ISIN like "CH0038863350" resolves to the LEGAL ENTITY that issued the security via the GLEIF ISIN-to-LEI mapping, covering non-US issuers EDGAR cannot reach), "drug" (returns RxCUI + ingredient + brand from RxNorm + pipeworx://rxnorm/concept/{rxcui} citation; accepts brand or generic name). LEI/FIGI enrichment degrades gracefully — if GLEIF or OpenFIGI is unavailable, the EDGAR identifiers still return. Each call cascades through several lookup endpoints internally — using resolve_entity replaces 2-3 manual lookups.

Input Schema

TableJSON Schema
NameRequiredDescriptionDefault
typeYesEntity type: "company" or "drug".
valueYesFor company: ticker (AAPL), CIK (0000320193), or name. For drug: brand or generic name (e.g., "ozempic", "metformin"). Pass the ENTITY NAME ONLY — for a bond that is the ISSUER exactly as printed ("NEW YORK ST DORM AUTH"), never the question's full noun phrase ("NEW YORK ST DORM AUTH revenue bonds"): the FIGI lookup matches instrument names, so trailing security-class words match nothing.

TDQS

A4.8/5.0
Behavior5/5

Does the description disclose side effects, auth requirements, rate limits, or destructive behavior?

Annotations already mark readOnly, openWorld, idempotent, non-destructive. The description goes far beyond, disclosing that the tool cascades through multiple endpoints, gracefully degrades when GLEIF/OpenFIGI are unavailable, labels each identifier with its source, lists unresolved identifiers explicitly, and returns candidates on ambiguity. No contradiction with annotations.

Agents need to know what a tool does to the world before calling it. Descriptions should go beyond structured annotations to explain consequences.

Conciseness4/5

Is the description appropriately sized, front-loaded, and free of redundancy?

The description is lengthy but dense; it front-loads usage examples and the 'Use FIRST' directive, then methodically covers supported types, edge cases, and error handling. Each sentence contributes meaningful information, so it earns its length, though slightly more trimming could make it snappier.

Shorter descriptions cost fewer tokens and are easier for agents to parse. Every sentence should earn its place.

Completeness5/5

Given the tool's complexity, does the description cover enough for an agent to succeed on first attempt?

For a complex tool with no output schema, the description explains return behavior (sources, unresolved list, figi_candidates), input constraints, graceful degradation, and the fact it replaces multiple lookups. It covers all aspects an agent needs to call it correctly, even without an output schema.

Complex tools with many parameters or behaviors need more documentation. Simple tools need less. This dimension scales expectations accordingly.

Parameters4/5

Does the description clarify parameter syntax, constraints, interactions, or defaults beyond what the schema provides?

Schema covers 100% of parameters with descriptions, but the description adds crucial nuance: for company type, it explains accepted ID formats (ticker, CIK, ISIN) and for drug type brand/generic names. It also stresses passing only the entity name, warning that trailing security-class words break matching for bonds. This enriches the schema without redundancy.

Input schemas describe structure but not intent. Descriptions should explain non-obvious parameter relationships and valid value ranges.

Purpose5/5

Does the description clearly state what the tool does and how it differs from similar tools?

The description explicitly states the verb 'resolve' and the resource (entity names to canonical identifiers), provides concrete example queries, and clarifies that it is the first port of call when a name needs an ID. It differentiates from siblings by noting it replaces 2-3 manual lookups, leaving no ambiguity about its function.

Agents choose between tools based on descriptions. A clear purpose with a specific verb and resource helps agents select the right tool.

Usage Guidelines5/5

Does the description explain when to use this tool, when not to, or what alternatives exist?

It explicitly says 'Use FIRST whenever you have a name but need an ID' and details supported input formats (ticker, CIK, ISIN, name) and entity types. It also gives context on ambiguous names by describing figi_candidates, and implies when not to use (when the ID is already known), making usage conditions clear.

Agents often have multiple tools that could apply. Explicit usage guidance like "use X instead of Y when Z" prevents misuse.

All Nasa Cmr toolsInspect
Try in Browser
RayrunBuild, deploy, and operate MCP servers without becoming an infrastructure team.ray.runAd

Glama MCP Gateway

Add one secure layer between your agents and this server.

TDQS

A3.5/5.0
Disambiguation2/5

The tool set mixes NASA-specific tools with a large number of financial and prediction market tools, causing confusion. Within the non-NASA tools, there is significant overlap (e.g., multiple Polymarket analysis tools, several research tools with vague boundaries).

Naming Consistency3/5

Most tools use snake_case, but naming patterns are inconsistent: some start with verbs (search_collections, get_collection), others are noun phrases (entity_profile, deep_research). There is no uniform verb_noun convention across the set.

Tool Count2/5

With 33 tools, the count is high. Although it may be appropriate for the underlying domain (data/prediction markets), it is excessive for the server's stated NASA focus, where only 3 tools are relevant.

Completeness1/5

For a server named 'Nasa Cmr', the tool set is severely incomplete: only three tools cover NASA Earth science (search/granules/collections), lacking any support for missions, datasets, or advanced queries. The non-NASA tools are comprehensive but disconnected from the server name.

Resources